Entity Common Stock, Shares Outstanding of VERTEX PHARMACEUTICALS INC / MA from 22 Apr 2010 to 06 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 22 Apr 2010 to 06 Feb 2026.
  • VERTEX PHARMACEUTICALS INC / MA Entity Common Stock, Shares Outstanding for the quarter ending 06 Feb 2026 was 254,034,190, a 1.1% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 254,034,190 -2,755,679 -1.1% 06 Feb 2026 10-K 13 Feb 2026 2025 FY
Q3 2025 253,718,831 -3,810,459 -1.5% 31 Oct 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 256,390,651 -1,711,552 -0.66% 31 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 256,797,187 -1,256,200 -0.49% 30 Apr 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 256,789,869 -1,517,947 -0.59% 07 Feb 2025 10-K 13 Feb 2025 2024 FY
Q3 2024 257,529,290 -153,894 -0.06% 31 Oct 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 258,102,203 +7,388 +0% 31 Jul 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 258,053,387 +501,787 +0.2% 30 Apr 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 258,307,816 +1,216,375 +0.47% 09 Feb 2024 10-K 15 Feb 2024 2023 FY
Q3 2023 257,683,184 +991,732 +0.39% 31 Oct 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 258,094,815 +1,635,333 +0.64% 31 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 257,551,600 +1,795,639 +0.7% 25 Apr 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 257,091,441 +2,514,750 +0.99% 31 Jan 2023 10-K 10 Feb 2023 2022 FY
Q3 2022 256,691,452 +2,439,514 +0.96% 21 Oct 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 256,459,482 -2,968,912 -1.1% 29 Jul 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 255,755,961 -3,109,710 -1.2% 29 Apr 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 254,576,691 -5,383,371 -2.1% 31 Jan 2022 10-K 09 Feb 2022 2021 FY
Q3 2021 254,251,938 -5,785,956 -2.2% 29 Oct 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 259,428,394 -1,038,940 -0.4% 23 Jul 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 258,865,671 -411,038 -0.16% 22 Apr 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 259,960,062 +691,469 +0.27% 31 Jan 2021 10-K 11 Feb 2021 2020 FY
Q3 2020 260,037,894 +2,888,306 +1.1% 23 Oct 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 260,467,334 +3,431,891 +1.3% 23 Jul 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 259,276,709 +3,155,349 +1.2% 24 Apr 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 259,268,593 +3,611,704 +1.4% 31 Jan 2020 10-K 13 Feb 2020 2019 FY
Q3 2019 257,149,588 +1,591,553 +0.62% 18 Oct 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 257,035,443 +1,475,504 +0.58% 26 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 256,121,360 +1,291,128 +0.51% 24 Apr 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 255,656,889 +1,764,905 +0.7% 31 Jan 2019 10-K 13 Feb 2019 2018 FY
Q3 2018 255,558,035 +2,655,187 +1% 19 Oct 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 255,559,939 +3,441,070 +1.4% 20 Jul 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 254,830,232 +5,761,450 +2.3% 20 Apr 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 253,891,984 +5,453,857 +2.2% 31 Jan 2018 10-K 15 Feb 2018 2017 FY
Q3 2017 252,902,848 +4,869,459 +2% 20 Oct 2017 10-Q 30 Oct 2017 2017 Q3
Q2 2017 252,118,869 +4,340,171 +1.8% 21 Jul 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 249,068,782 +1,718,918 +0.7% 21 Apr 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 248,438,127 +2,046,172 +0.83% 10 Feb 2017 10-K 23 Feb 2017 2016 FY
Q3 2016 248,033,389 +2,316,103 +0.94% 21 Oct 2016 10-Q 31 Oct 2016 2016 Q3
Q2 2016 247,778,698 +3,123,171 +1.3% 22 Jul 2016 10-Q 01 Aug 2016 2016 Q2
Q1 2016 247,349,864 +3,597,617 +1.5% 20 Apr 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 246,391,955 +4,303,071 +1.8% 31 Jan 2016 10-K 16 Feb 2016 2015 FY
Q3 2015 245,717,286 +5,195,477 +2.2% 23 Oct 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 244,655,527 +6,573,994 +2.8% 24 Jul 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 243,752,247 +7,557,910 +3.2% 24 Apr 2015 10-Q 04 May 2015 2015 Q1
Q4 2014 242,088,884 +6,316,942 +2.7% 31 Jan 2015 10-K 13 Feb 2015 2014 FY
Q3 2014 240,521,809 +6,764,938 +2.9% 31 Oct 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 238,081,533 +5,269,232 +2.3% 25 Jul 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 236,194,337 +14,793,473 +6.7% 25 Apr 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 235,771,942 05 Feb 2014 10-K 11 Feb 2014 2013 FY
Q3 2013 233,756,871 +16,929,805 +7.8% 31 Oct 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 232,812,301 +17,004,819 +7.9% 26 Jul 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 221,400,864 +10,339,716 +4.9% 26 Apr 2013 10-Q 08 May 2013 2013 Q1
Q3 2012 216,827,066 +8,260,872 +4% 26 Oct 2012 10-Q 06 Nov 2012 2012 Q3
Q2 2012 215,807,482 +7,719,583 +3.7% 27 Jul 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 211,061,148 +5,063,304 +2.5% 27 Apr 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 210,335,993 +5,923,281 +2.9% 08 Feb 2012 10-K 22 Feb 2012 2011 FY
Q3 2011 208,566,194 +5,371,972 +2.6% 28 Oct 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 208,087,899 +5,256,287 +2.6% 29 Jul 2011 10-Q 09 Aug 2011 2011 Q2
Q1 2011 205,997,844 +3,794,932 +1.9% 28 Apr 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 204,412,712 09 Feb 2011 10-K 17 Feb 2011 2010 FY
Q3 2010 203,194,222 21 Oct 2010 10-Q 28 Oct 2010 2010 Q3
Q2 2010 202,831,612 29 Jul 2010 10-Q 03 Aug 2010 2010 Q2
Q1 2010 202,202,912 22 Apr 2010 10-Q 03 May 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.